dc.contributor.author | Cameron, Sharon T | |
dc.contributor.author | Glasier, Anna | |
dc.contributor.author | McDaid, Lisa | |
dc.contributor.author | Radley, Andrew | |
dc.contributor.author | Baraitser, Paula | |
dc.contributor.author | Stephenson, Judith M | |
dc.contributor.author | Gilson, Richard | |
dc.contributor.author | Battison, Claire G. | |
dc.contributor.author | Cowle, Kathleen | |
dc.contributor.author | Forrest, Mark | |
dc.contributor.author | Goulao, Beatriz | |
dc.contributor.author | Johnstone, Anne | |
dc.contributor.author | Morelli, Alessandra | |
dc.contributor.author | Patterson, Susan | |
dc.contributor.author | McDonald, Alison | |
dc.contributor.author | Vadiveloo, Thenmalar | |
dc.contributor.author | Norrie, John | |
dc.date.accessioned | 2020-11-23T15:37:01Z | |
dc.date.available | 2020-11-23T15:37:01Z | |
dc.date.issued | 2020-11-14 | |
dc.identifier.citation | Cameron , S T , Glasier , A , McDaid , L , Radley , A , Baraitser , P , Stephenson , J M , Gilson , R , Battison , C G , Cowle , K , Forrest , M , Goulao , B , Johnstone , A , Morelli , A , Patterson , S , McDonald , A , Vadiveloo , T & Norrie , J 2020 , ' Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It) : a pragmatic cluster-randomised crossover trial ' , The Lancet , vol. 396 , no. 10262 , pp. 1585-1594 . https://doi.org/10.1016/S0140-6736(20)31785-2 | en |
dc.identifier.issn | 0140-6736 | |
dc.identifier.other | PURE: 180240037 | |
dc.identifier.other | PURE UUID: 6413ea62-9c09-45c9-85fc-54dd919cdb04 | |
dc.identifier.other | Scopus: 85096153496 | |
dc.identifier.other | PubMed: 33189179 | |
dc.identifier.other | WOS: 000588778800030 | |
dc.identifier.uri | https://hdl.handle.net/2164/15399 | |
dc.description | Acknowledgments: We thank the participants of this study, community pharmacists who recruited women for the study, and health-care professionals at the sexual and reproductive health service clinics who assisted with the study implementation. We thank Deirde Sally, Nicola Stewart, and Maria Nunez for the support with study implementation at the local site in London and Kristina Saunders for support with the process evaluation. We also thank Sarah Cameron and Lorna Aucott (senior statistician, the Centre for Healthcare Randomised Trials) for support and Katherine Lewis, Laura Flett, and Judith Parker for trial management support. List of study pharmacies in Edinburgh: Newington Pharmacy, Boots Princes Street, Boots Shandwick Place, Boots Earl Grey Street, Boots Gyle, Boots St Patrick Street, Boots Multrees Walk, Boots Ocean Terminal, Boots Edinburgh Fort Retail Park, Boots Cameron Toll, Boots Craigleith, and Bristo Square Pharmacy. List of study pharmacies in London: Peace Pharmacy, Westbury Chemist, Baba Chemist, Lings Chemist, Streatham Day Lewis, Morrisons—Aylesham Centre, Evergreen Pharmacy, Greenlight Pharmacy, Sandylight Pharmacy, Greenfields, JP Pharmacy, Boots Goodge Street, Boots Tottenham Court Road, and Boots Holborn. Additionally, Asda Pharmacy (Perth), Boots High Street and Boots Perth Road (Dundee). List of sexual and reproductive health clinics: Chalmers Sexual and Reproductive Health Service, NHS Lothian (Edinburgh), Tayside Sexual and Reproductive Health Service, Ninewells Hospital (Dundee), Camberwell Sexual Health Centre, Mortimer Market Centre, the Margaret Pyke Centre, and the Archway Centre (London). Declaration of interests: STC reports grants from the National Institute for Health Research (Health Technology Assessment [NIHR HTA] Programme), during the conduct of the study. AG is a consultant to HRA Pharma. AR reports receiving research grants from Gilead Sciences, Bristol-Myers Squibb, AbbVie, and Roche; honorariums from Gilead Sciences; and personal fees from AbbVie. LM and SP report funding from the UK Medical Research Council and Scottish Government Chief Scientist Office (Central Statistics Office) at the University of Glasgow (MC_UU_12017/11, SPHSU11). PB is a clinical director of the not-for profit community interest company SH:24, that provides online sexual health services in partnership with the UK National Health Service. KC reports being an employee of Boots UK, during the conduct of this study. AleM reports grants from NIHR HTA, during the conduct of this study. AleM is a clinical support bank midwife for SH:24 and a research midwife at Oxford University. JN was a deputy chair of the NIHR HTA General Board Committee (2016–19). All other authors declare no competing interests. This research is funded by the NIHR HTA project 15/113/01. | en |
dc.format.extent | 10 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Lancet | en |
dc.rights | © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | R Medicine | en |
dc.subject | Medicine(all) | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | MC_UU_12017/11 | en |
dc.subject | Chief Scientist Office (CSO) | en |
dc.subject | SPHSU11 | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject | 15/113/01 | en |
dc.subject.lcc | RA0421 | en |
dc.subject.lcc | R | en |
dc.title | Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It) : a pragmatic cluster-randomised crossover trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1016/S0140-6736(20)31785-2 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85096153496&partnerID=8YFLogxK | en |
dc.identifier.vol | 396 | en |
dc.identifier.iss | 10262 | en |